SOLUTIONS MEDICALISEES ADAPTEES SMA : revenue, balance sheet and financial ratios

SOLUTIONS MEDICALISEES ADAPTEES SMA is a French company founded 17 years ago, specialized in the sector Conseil pour les affaires et autres conseils de gestion. Based in VILLENEUVE-D'ASCQ (59650), this company of category GE shows in 2024 a revenue of 96 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SOLUTIONS MEDICALISEES ADAPTEES SMA (SIREN 508156882)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017
Revenue 96 301 € 109 942 € 81 477 € 109 059 € 105 008 € 103 400 € 97 104 € N/C
Net income 10 806 € 9 496 € 2 669 € 2 114 € 3 349 € 601 € -2 658 € -40 816 €
EBITDA 10 842 € 12 638 € 3 599 € 4 170 € 4 369 € 2 805 € -951 € N/C
Net margin 11.2% 8.6% 3.3% 1.9% 3.2% 0.6% -2.7% N/C

Revenue and income statement

In 2024, SOLUTIONS MEDICALISEES ADAPTEES SMA achieves revenue of 96 k€. Activity remains stable over the period (CAGR: -0.1%). Significant drop of -12% vs 2023. After deducting consumption (0 €), gross margin stands at 96 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 11 k€, representing 11.3% of revenue. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 11 k€, i.e. 11.2% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

96 301 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

96 301 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

10 842 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

10 806 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

10 806 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

11.3%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at -114%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -533%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 32.5 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 11.2% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

-114.084%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

-533.116%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

11.221%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

32.482

Solvency indicators evolution
SOLUTIONS MEDICALISEES ADAPTEES SMA

Sector positioning

Debt ratio
-114.08 2024
2022
2023
2024
Q1: 0.0
Med: 3.99
Q3: 41.75
Excellent

In 2024, the debt ratio of SOLUTIONS MEDICALISEES AD... (-114.08) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
-533.12% 2024
2022
2023
2024
Q1: 4.19%
Med: 38.81%
Q3: 76.4%
Average

In 2024, the financial autonomy of SOLUTIONS MEDICALISEES AD... (-533.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
32.48 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.0 years
Q3: 1.1 years
Average

In 2024, the repayment capacity of SOLUTIONS MEDICALISEES AD... (32.48) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 401.31. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

401.307

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

0.0

Liquidity indicators evolution
SOLUTIONS MEDICALISEES ADAPTEES SMA

Sector positioning

Liquidity ratio
401.31 2024
2022
2023
2024
Q1: 138.7
Med: 312.74
Q3: 965.51
Good +28 pts over 3 years

In 2024, the liquidity ratio of SOLUTIONS MEDICALISEES AD... (401.31) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
0.0x 2024
2022
2023
2024
Q1: 0.0x
Med: 0.0x
Q3: 0.26x
Average -50 pts over 3 years

In 2024, the interest coverage of SOLUTIONS MEDICALISEES AD... (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 151 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 2 days. The gap of 149 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Overall, WCR represents 140 days of revenue, i.e. 37 k€ to permanently finance.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

37 485 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

151 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

2 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

140 j

WCR and payment terms evolution
SOLUTIONS MEDICALISEES ADAPTEES SMA

Positioning of SOLUTIONS MEDICALISEES ADAPTEES SMA in its sector

Comparison with sector Conseil pour les affaires et autres conseils de gestion

Valuation estimate

Based on 69 transactions of similar company sales in 2024, the value of SOLUTIONS MEDICALISEES ADAPTEES SMA is estimated at 57 087 € (range 21 319€ - 95 475€). With an EBITDA of 10 842€, the sector multiple of 4.3x is applied. The price/revenue ratio is 0.66x (in line with sector norms). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2024
69 tx
21k€ 57k€ 95k€
57 087 € Range: 21 319€ - 95 475€
NAF 5 année 2024

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
10 842 € × 4.3x
Estimation 46 169 €
9 179€ - 73 918€
Revenue Multiple 30%
96 301 € × 0.66x
Estimation 63 453 €
36 928€ - 70 163€
Net Income Multiple 20%
10 806 € × 6.9x
Estimation 74 837 €
28 257€ - 187 338€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 69 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Conseil pour les affaires et autres conseils de gestion)

Compare SOLUTIONS MEDICALISEES ADAPTEES SMA with other companies in the same sector:

Voir toutes les statistiques du secteur Conseil pour les affaires et autres conseils de gestion

Frequently asked questions about SOLUTIONS MEDICALISEES ADAPTEES SMA

What is the revenue of SOLUTIONS MEDICALISEES ADAPTEES SMA ?

The revenue of SOLUTIONS MEDICALISEES ADAPTEES SMA in 2024 is 96 k€.

Is SOLUTIONS MEDICALISEES ADAPTEES SMA profitable?

Yes, SOLUTIONS MEDICALISEES ADAPTEES SMA generated a net profit of 11 k€ in 2024.

Where is the headquarters of SOLUTIONS MEDICALISEES ADAPTEES SMA ?

The headquarters of SOLUTIONS MEDICALISEES ADAPTEES SMA is located in VILLENEUVE-D'ASCQ (59650), in the department Nord.

Where to find the tax return of SOLUTIONS MEDICALISEES ADAPTEES SMA ?

The tax return of SOLUTIONS MEDICALISEES ADAPTEES SMA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SOLUTIONS MEDICALISEES ADAPTEES SMA operate?

SOLUTIONS MEDICALISEES ADAPTEES SMA operates in the sector Conseil pour les affaires et autres conseils de gestion (NAF code 70.22Z). See the 'Sector positioning' section above to compare the company with its competitors.